Clinical Report: Alterations in Fatty Acid Metabolism Across Neuronal Subtypes in Schizophrenia
Overview
This study identifies cell type-specific alterations in fatty acid metabolism-related genes in the dorsolateral prefrontal cortex of schizophrenia patients. A five-gene diagnostic model was developed, demonstrating reliable predictive performance for schizophrenia diagnosis.
Background
Schizophrenia is a complex psychiatric disorder affecting approximately 1% of the global population, characterized by a range of symptoms that significantly impact patients' quality of life. Understanding the molecular mechanisms underlying schizophrenia is crucial for developing precise diagnostic and therapeutic strategies. Recent advances in sequencing technologies have highlighted the importance of fatty acid metabolism in neuropsychiatric disorders, yet its role in schizophrenia remains poorly understood.
Data Highlights
Model Performance
AUC
Training Cohort
0.856
Validation Cohort
0.779
Key Findings
Specific neuronal subtypes (CUX2+ NeuN and OPRM1+ NeuN) were significantly upregulated in schizophrenia patients.
Five key genes (ACAA1, ACAT2, ACSS1, PSME1, S100A10) were identified as associated with schizophrenia pathogenesis.
These genes showed significant negative correlations with inflammatory genes (p < 0.05).
The diagnostic model demonstrated reliable predictive performance with AUC values of 0.856 and 0.779 in training and validation cohorts, respectively.
Significant differential expression of related genes was confirmed in an MK-801-induced mouse model of schizophrenia (p < 0.001).
Clinical Implications
The identification of fatty acid metabolism-related genes as potential biomarkers for schizophrenia may enhance diagnostic accuracy and facilitate early intervention strategies. Clinicians should consider the implications of metabolic dysregulation in the management of schizophrenia.
Conclusion
This study underscores the importance of fatty acid metabolism in schizophrenia and presents a promising diagnostic model that could improve clinical outcomes through targeted interventions.
Swedish study finds two-way associations between premenstrual disorders and psychiatric conditions, with strongest links involving depression, anxiety, attention-deficit/hyperactivity disorder, bipolar disorder, and personality disorders.
